Tuberculosis (TB) deaths fell to about 1.13 million in 2025, and more countries are increasing their own investment in TB care, according to the World Health Organization’s Global Tuberculosis Report 2026, released on 12 November.
The report shows TB incidence fell to 129 new cases per 100,000 people in 2025, down 1.6% from 2024, and deaths fell 4%. Since 2015, incidence has dropped 14% and deaths 35%. But these gains are far behind the End TB Strategy target of halving incidence by 2025. Total funding for TB prevention, diagnosis and treatment reached $6.6 billion in 2025, only about 30% of the $22 billion needed each year by 2027. India and Indonesia showed the largest increases in domestic funding. Thirty high-burden countries account for 88% of all cases.

Imagine a TB nurse in Lagos visiting a young mother who was diagnosed with tuberculosis two months ago. At first, she coughed for weeks and thought it was just a cold that wouldn’t go away. Now, after daily treatment, she has gained weight, her cough has eased, and she can care for her baby again. The nurse checks that she is taking every dose, screens her household for symptoms, and arranges preventive treatment for her child. Each conversation like this helps to break the chain of transmission. WHO’s latest report shows that this kind of care is saving lives, but there are still far too many people waiting to be found and treated.
What happened
WHO released its Global Tuberculosis Report 2026 on 12 November 2026. It covers data for 2025 from countries around the world.
The report found that the TB incidence rate fell to 129 new cases per 100,000 people in 2025, down from 131 in 2024. About 1.13 million people died from TB in 2025, down 4% from 1.18 million the year before.
WHO highlighted that, amid challenges, countries are increasing domestic investment to protect progress. Total funding reached $6.6 billion, but some high-burden countries saw overall funding fall in 2025, and the report warns that the effects of international funding cuts may take time to appear in the data.
10 key facts
- WHO’s Global Tuberculosis Report 2026 was released on 12 November.
- About 1.13 million people died from TB in 2025.
- TB deaths fell 4% from 2024 and 35% since 2015.
- TB incidence was 129 cases per 100,000 people in 2025.
- Incidence has fallen only 14% since 2015, far short of the 50% target.
- TB funding reached $6.6 billion in 2025.
- That is about 30% of the $22 billion annual target for 2027.
- India and Indonesia had the largest increases in domestic TB funding.
- Thirty countries account for 88% of TB cases.
- TB is preventable and curable.
The numbers at a glance
- 129 new TB cases per 100,000 people in 2025 (131 in 2024)
- 1.13 million TB deaths in 2025 (1.18 million in 2024)
- Deaths down 35% since 2015 (1.74 million)
- Incidence down 14% since 2015
- $6.6 billion TB funding in 2025
- $22 billion needed annually by 2027
- 30 high-burden countries: 88% of cases
- India 25%, Indonesia 10%, Philippines 6.8%, China 6.5%, Pakistan 6.4%, Nigeria 4.9%, DR Congo 3.9%, Bangladesh 3.7%
- Cases by group: 54% men, 35% women, 11% children
What is tuberculosis?
Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It most often affects the lungs but can affect other parts of the body, including lymph nodes, bones, the brain and the spine.
TB spreads through the air when a person with active lung TB coughs, sneezes or speaks. Not everyone infected becomes ill. About a quarter of the world’s population is thought to carry the bacteria in an inactive (latent) form, and some will develop active disease later, especially if their immune system is weakened by HIV, malnutrition, diabetes or smoking.
Symptoms of active TB include a cough lasting more than two weeks, coughing up blood, fever, night sweats, weight loss and tiredness. TB is curable with a course of antibiotics, usually lasting several months, and drug-resistant TB requires longer or different treatment.
Why this matters
TB remains one of the world’s leading infectious killers. The fall in deaths shows that diagnosis and treatment are working, but progress is slow, and the End TB Strategy’s first milestone, originally due in 2020, was only reached in 2025.
Funding gaps threaten progress. With total funding at about 30% of what is needed, many people with TB are still not diagnosed or treated, and research on new vaccines and treatments is underfunded.
Growing domestic investment, especially in high-burden countries like India and Indonesia, is a positive sign that governments are taking ownership of their TB response.
What officials and experts said
Dr Tereza Kasaeva, WHO Director for HIV, TB, Hepatitis and STIs, said total funding for TB prevention, diagnosis and treatment ‘reached $6.6 billion’.
Dr Katherine Floyd, head of WHO’s monitoring, evaluation and strategic information unit, said ‘most indicators of progress moved slowly in the right direction or were relatively stable between 2024 and 2025’. She warned that the impact of funding cuts may be delayed in the data.
What this means for you
- See a health worker if you have a cough lasting more than two weeks, night sweats or weight loss.
- TB testing and treatment are free in many countries.
- If you are diagnosed, take every dose of treatment as advised.
- Household contacts should be checked and may be offered preventive treatment.
- People living with HIV should be screened for TB regularly.
- Open windows and good ventilation reduce spread at home.
What this means for nurses and health workers
Nurses are at the heart of TB care, from case finding to supporting people through months of treatment.
- Screen for TB symptoms in every patient with a long-lasting cough.
- Collect good-quality sputum samples.
- Support treatment adherence with respect and practical help.
- Trace and screen household contacts.
- Offer TB preventive treatment where indicated.
- Reduce stigma through clear, compassionate communication.
The global picture
Eight countries account for about two-thirds of all TB cases: India (about 25%), Indonesia (10%), the Philippines (6.8%), China (6.5%), Pakistan (6.4%), Nigeria (4.9%), the Democratic Republic of the Congo (3.9%) and Bangladesh (3.7%). Men account for 54% of cases, women 35% and children 11%. Nigeria remains among the countries with the highest TB burden in Africa.
Drug-resistant TB
Some TB bacteria are resistant to the most effective medicines. Drug-resistant TB requires different treatment, though newer all-oral regimens are shorter and easier to take than older ones. Taking treatment correctly helps prevent resistance developing.
TB and HIV
People living with HIV are much more likely to develop active TB. Combined testing and treatment for both infections saves lives.
TB preventive treatment
People at high risk, such as household contacts and people living with HIV, can take preventive treatment to stop latent infection becoming active disease.
Families and close contacts of people with tuberculosis should be checked for symptoms, and young children in the household may be offered preventive treatment to protect them.
Stigma
Fear of discrimination stops some people seeking care. TB is curable, and people on effective treatment quickly become non-infectious.
Stigma also affects health workers, so workplace screening and support matter too.
Nutrition and TB
Undernutrition increases the risk of TB and slows recovery. Food support improves treatment outcomes.
Vaccines
The BCG vaccine protects young children against severe forms of TB. New TB vaccines are being tested in clinical trials.
Finding the missing people with tuberculosis
Every year, millions of people who develop tuberculosis are not diagnosed or not reported to national programmes. Some never reach a health facility, some are treated in private clinics without notification, and others are told they have a chest infection and given antibiotics that don’t cure TB. Finding these ‘missing’ people is one of the biggest challenges in TB control. Approaches that help include active case finding in high-risk communities, screening in prisons, mines and informal settlements, chest X-rays with computer-aided reading, and rapid molecular tests that give results within hours. Engaging private pharmacies and clinics to refer people with long-lasting coughs is also important. Each person found and treated early not only recovers but also stops passing the infection to family, colleagues and neighbours.
Supporting people through treatment
Tuberculosis treatment lasts months, and many people feel better long before the course is complete. Side effects, travel costs, lost income and stigma can make it hard to continue. Nurses and community health workers can help by explaining why every dose matters, checking for side effects, offering flexible appointments, and linking people to food and social support. Digital tools, such as video-observed treatment and medication reminders, are helping some programmes. Respectful, person-centred support improves treatment success and reduces the risk of drug resistance.
Myths and facts
Myth: TB is a disease of the past.
Fact: It still kills over a million people a year.
Myth: TB can’t be cured.
Fact: It is curable with a full course of treatment.
Myth: TB is hereditary.
Fact: It is caused by bacteria spread through the air.
Myth: You must stay isolated for the whole treatment.
Fact: Most people become non-infectious soon after starting effective treatment.
Questions and answers
How many people died from TB in 2025?
About 1.13 million.
Is TB increasing?
Incidence and deaths fell slightly in 2025.
Which countries have the most TB?
India, Indonesia, the Philippines and China lead.
Is TB treatment free?
In many countries, yes.
How long is treatment?
Usually several months.
Can children get TB?
Yes, children make up 11% of cases.
Is funding enough?
No, it is about 30% of what is needed.
What happens next
WHO urges countries to close funding gaps, expand rapid testing, roll out shorter treatments and preventive therapy, and invest in research for new vaccines. The next major milestones are the 2027 funding target and the 2030 End TB goals.
Key takeaways
- WHO’s Global Tuberculosis Report 2026 was released on 12 November.
- TB deaths fell 4% from 2024 and 35% since 2015.
- Incidence has fallen only 14% since 2015, far short of the 50% target.
- That is about 30% of the $22 billion annual target for 2027.
- Thirty countries account for 88% of TB cases.
- TB is preventable and curable.
How we report health news
Nursing Media Network reports health news using official sources such as the World Health Organization, national public health agencies, medicines regulators and peer-reviewed research, which are linked at the end of each story. Figures in fast-moving stories, such as outbreaks, change quickly, so we state the date each number refers to. If you are reading this later, check the latest update from the official source before making decisions.
News reports describe what has happened across a population. They cannot tell you what is right for your own health. If a story raises questions about your treatment, symptoms or risk, speak to your nurse or healthcare provider before making any changes.
Finding reliable health information
Health information online varies widely in quality. Prefer sources such as the World Health Organization, national health ministries, public health agencies, university hospitals and registered professional bodies. Be cautious with social media posts, miracle cures and products sold with promises that sound too good to be true.
If you read something that worries you or contradicts the advice you have been given, write it down and discuss it with your nurse or healthcare provider. They can explain how it applies to your own situation and help you separate evidence from rumour.
Questions to ask your nurse or healthcare provider
- Should I be tested for TB?
- How long will my treatment last?
- What side effects should I watch for?
- Should my family be screened?
- Can I continue working during treatment?
- Is preventive treatment right for me?
But isn’t TB now rare?
No. TB still kills over a million people a year and is common in many countries, including Nigeria.
Your next step: If you or someone in your home has had a cough for more than two weeks, ask a nurse about a TB test.
Related: Tuberculosis · HIV · Silicosis · Pneumonia
Sources: Health Policy Watch; CIDRAP; WHO: tuberculosis fact sheet.



Leave a Reply